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Available online xxxxOlfactory impairment might be useful as a non-invasive pre-morbid biological marker of psychosis. People with
schizophrenia show consistent impairments, but an association between olfaction and schizotypy in non-clinical
populations is inconclusive and has been somewhat controversial. This is important as impairment in patients
may be artefacts of antipsychotic medication. Meta-analyses indicate small effect sizes in non-clinical popula-
tions, suggesting prior negative studies may have been underpowered to demonstrate them.
We measured olfaction and psychometrically-deﬁned schizotypy in a sample of 739 non-clinical volunteers
[mean age 23.1]. Subsets reported whether they had a history of mental illness in the family or smoked. We
used (snifﬁn’ sticks) to measure threshold detection, discrimination and identiﬁcation of odours. O-LIFE was
used to measure schizotypy.
Lower olfactory-threshold selectively predicted higher scores on the positive dimension, unusual experiences.
This associationwasmost evident in sub-groups reporting history ofmental illness in the family and/or smoking.
There was a weak trend for an association between identiﬁcation and introvertive anhedonia and discrimination
and cognitive disorganisation in those with a history of mental illness in the family.
These data support the idea that olfaction merits further investigation as a biomarker for psychosis and that
olfactory-threshold detection in particular has potential to selectively predict unusual experiences. Variability
in previous studies may have been exacerbated by including different proportions of participants with history
of mental illness in the family and/or smoking. We propose that non-clinical participants be stratiﬁed by these
factors in future studies of olfaction and potentially any study that measures psychometric schizotypy.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Schizophrenia1. Introduction
A number of studies have found that people with psychosis and
schizophrenia have abnormal olfactory abilities, with most, but not all,
ﬁnding impairment (Bradley, 1984; Brewer et al., 1996; Corcoran
et al., 2005; Good and Sullivan, 2015; Kamath et al., 2018; Moberg
et al., 2014; Robabeh et al., 2015). Olfaction is established early in em-
bryonic development, being fully functional by approximately week
24 of gestation. The neural circuitry underlying olfaction comprises re-
gions implicated in schizophrenia including subregions of the frontal
cortex, the amygdala, hippocampus and the parahippocampal gyrus
(Gottfried and Zald, 2005; Harrison, 1999; Kamath et al., 2014;
Malaspina et al., 1998; Schneider et al., 2007; Turetsky et al., 2009).
For these reasons impaired olfaction is of interest as a potential bio-
behavioural marker for early neurodevelopmental abnormalities that
precede the onset of the symptoms of schizophrenia in adolescence
and adulthood. Olfactory deﬁcits were originally described in
Parkinson's and Alzheimer's Diseases and there is recent evidence for, University of Nottingham,
Moran).
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chres.2019.05.014deﬁcits associated with mood disorders, (Foguem et al., 2018; Naudin
et al., 2014; Olofsson et al., 2016) and with 22q11 syndrome associated
with psychosis (Tang et al., 2018). This suggests that the impairments
may have wider bio-marker application across multiple neuropsychiat-
ric and neurological disorders.
Olfaction can be considered to involve at least three separate sub-
processes, Identiﬁcation; the ability to identify or name an odour, dis-
crimination the ability to discriminate one odour from another and
Threshold; the ability to detect speciﬁc odours above background. Dif-
ferent studies measuring olfaction in schizophrenia and schizotypy
have used different methods to measure olfaction, with only a few
analysing all three aspects e.g. (Kamath et al., 2018). There is evidence
for speciﬁc deﬁcits in identiﬁcation in people with schizophrenia.
(Park and Schoppe, 1997) found that psychometrically deﬁned
schizotypal men, but not women, showed olfactory identiﬁcation deﬁ-
cits. (Brewer et al., 2003) found impairment of identiﬁcation in individ-
uals identiﬁed as high risk for developing psychosis who later
developed schizophrenia or schizophreniform psychosis. However,
there was no evidence of lower olfactory identiﬁcation scores in those
classiﬁed as high riskwhowent on to develop other psychotic disorders.
This suggests olfactory identiﬁcationmayhave some speciﬁcity as a pre-
morbid marker of transition from high risk to schizophrenia. (Kamaththe CC BY license (http://creativecommons.org/licenses/by/4.0/).
reshold selectively predicts positive psychometric schizotypy, Schizo-
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identiﬁcation between individuals scoring high and low in schizotypy.
(Compton and Chien, 2008) also found no relationship between olfac-
tory identiﬁcation and schizotypy in ﬁrst-degree relatives of those
with schizophrenia. Using discrimination as the olfactory measure
(Kamath et al., 2014) found that clinical risk subjects showed robust im-
pairments in olfactory discrimination aswell as identiﬁcation. However,
some studies have failed to ﬁnd a discrimination deﬁcit in individuals
with schizotypy (Zou et al., 2015). Relatively fewer studies have inves-
tigated olfactory threshold in connection with schizotypy. Whilst Park
and Schoppe (1997) failed to ﬁnd a relationship between threshold
and Schizotypy, one study by Mohr, Rohrenbach, Laska and Brugger
(2001) found elevated detection thresholds (diminished acuity) in indi-
viduals who scored at or above themedian magical ideation score com-
pared to those who scored below.
Schizotypy is a psychometrically deﬁned, hypothetical personality
construct, linked to a developmental theory of latent susceptibility to
schizophrenia (Korﬁne and Lenzenweger, 1995). Schizotypy is consid-
ered in terms of the dimensional or “quasi-dimensional” view that traits
that correspond to various dimensions of schizophrenia are seen to
varying degrees in the general population. There are signiﬁcant num-
bers of individuals who have psychotic experiences within the general
population (Linscott and van Os, 2013; van Os et al., 2009) and
taxonometric studies investigating the latent class structure of
schizotypy, conﬁrm that many symptoms associated with psychosis
exist on a dimension in the general population (Elahi et al., 2017;
Grant et al., 2018). The dimensional or personality-based approach sug-
gests a continuum that includes all of the populationwith schizophrenia
at the extreme end (Claridge and Beech, 1995), (Grant et al., 2018;
Rawlings et al., 2008). In support of this approach a number of studies
have found that particularly positive symptoms such as hearing voices
are relatively prevalent in the general population (Linscott and van Os,
2013; van Os, 2003). The “quasi-dimensional” or disease-based ap-
proach suggests that schizotypy refers to a small percentage (estimates
vary between 3 and 10%) of the population who carry very speciﬁc, po-
tentially genetic, vulnerability to schizophrenia; reviewed in (Claridge
and Beech, 1995; Grant et al., 2018; Nelson et al., 2013). Studies investi-
gating the association between olfaction and schizotypy have not con-
sistently used one approach or the other. While there is a difference of
opinion about the factor structure of schizotypy there is good agree-
ment that it comprises at least three distinguishable factors which cor-
respond to positive, negative and disorganised symptomsdimensions in
schizophrenia (Fonseca-Pedrero et al., 2011; Nelson et al., 2013). The O-
LIFE questionnaire used in the present study include scales derived from
DSM description of these symptoms.
(Cohen et al., 2012) controversially suggested that olfactory deﬁcits
in schizotypy are subtle, if at all present and that they do not constitute a
meaningful vulnerability marker. A subsequent meta-analysis found
that olfactory deﬁcits (which combined differentmeasures of olfaction)
are associated with small effect sizes in individuals who scored high in
schizotypy (Moberg et al., 2014). Given the variability in the way both
olfaction and schizotypy are deﬁned and measured across studies,
coupled with the likely lack of experimental power in the majority of
studies, it is difﬁcult tomake deﬁnitive conclusions about whether indi-
viduals with high psychometrically deﬁned schizotypy show olfactory
impairments. This is an important question in the context of using olfac-
tion as a potential biomarker for future psychosis. In this study we in-
vestigated olfactory performance across three measures of olfaction:
identiﬁcation, discrimination, and threshold using snifﬁn’ sticks
(Hummel et al., 2007). We measured schizotypy using the O-LIFE
(Mason and Claridge, 2006; Mason et al., 1995), a scale that measures
positive, negative and cognitive related symptomatology in a majority
young adult population. Results suggest that olfactory threshold is a
weak but selective predictor of unusual experiences but that this is
moderated by whether individuals report current smoking and/or his-
tory of mental illness in the family.Please cite this article as: N. Mathur, C. Dawes and P.M.Moran, Olfactory th
phrenia Research, https://doi.org/10.1016/j.schres.2019.05.0142. Methods
2.1. Participants
The studywas carried out under the ethical approval of the School of
Psychology, University of Nottingham, Ethics Committee. A total of 739
participants (264 M /475 F, mean age 23.1, S.D. 9.28) were recruited in
seven cohorts between 2012 and 2018. N numbers for each cohortwere
73, 141, 126, 102, 100, 40 and 149 respectively. Mostly participants
were recruited as an opportunity sample. Some students were 1st
year psychology students from the University of Nottingham who
were reimbursed with participation credits. Participants who had re-
cently chewed gum (in past 3 h), or had a respiratory infectionwere ex-
cluded from the study (n = 8). There was some variability between
cohorts in terms of olfactory scores, however we did not consider vari-
ability large enough to warrant normalisation [highest mean TDI score
was 31.6 (2016 cohort) and the lowest 27.9 (2018 cohort)] (see supple-
mentary information section for full scores).A short demographics
questionnaire was given to all participants either prior to the study or
prior to olfactory testing. This requested age, sex, and whether they
were currently taking anymedications and if so which ones - theword-
ing differed slightly but not substantively between cohorts e.g. text of
question [“Are you currently on any medication (including contracep-
tion)? Yes/No /Prefer not to say If so, please specify:”]. None reported
taking antipsychotic medication, the most frequently reported medica-
tions were contraceptives, acne-medication/roaccutane, anti-
depressants and salbutamol inhalers. Some cohorts additionally com-
pleted questions whether they smoked cigarettes (Yes/No/Prefer not
to say), whether they smoked cannabis (Yes/No/Prefer not to say) and
whether there was a history of mental illness in their family (Yes/No/
Prefer not to say). Some additional details were requested in some sin-
gle cohorts (e.g. stage of menstrual cycle, education level) but as they
were not collected systematically or in sufﬁcient numbers of cohorts
they are not reported.2.2. Olfaction (Snifﬁn’ sticks)
The Snifﬁn’ Sticks test used is a reliable andwidely used test that has
been validated for European populations (Haehner et al., 2009;
Hummel et al., 2007; Hummel et al., 1997). It includes threshold, dis-
crimination and identiﬁcation tests using odour dispensing felt-pens
(14 cm in length, 1.3 cm inner diameter). Each pen contains 4 ml of ei-
ther a liquid odour or an odour that had been dissolved in propylene
glycol.
Threshold levels were assessed using n-butanol detection. The test
consisted of 16 pen-triplets, thosemarkedwith higher numbers indicat-
ing a lower dilution of n-butanol (i.e.1was the strongest and 16was the
weakest dilutionwith 4%n-butanol). Two of the pens dispensed propyl-
ene glycol and one the target odour (n-butanol). The discrimination test
consisted of 16 pen-triplets; within each triplet 2 pens dispensed the
same odour, one dispensed a different odour. The identiﬁcation test
consisted of 16 pens with different common odours and 16 cards nam-
ing 4 alternative odours to select from.2.3. Schizotypy (O-LIFE)
TheOxford-Liverpool Inventory of Feelings and Experiences (O-LIFE;
Mason and Claridge, 2006, (Mason and Claridge, 2006) (150 questions,
YES-NO format) was used to assess participants level of schizotypy. 104
of the questions were scored, the additional questions were ﬁller ques-
tions (score range: 0–104). The 104 scored questions measured 4 di-
mensions. There were 30 questions on “unusual experiences”, 24 on
“cognitive disorganisation”; 27 on “introvertive anhedonia” and 23
assessing “impulsive nonconformity” dimensions.reshold selectively predicts positive psychometric schizotypy, Schizo-
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The olfaction tests were conducted in the order: threshold, discrim-
ination, identiﬁcation. To avoid confounds by visual input participants
wore a blindfold during the threshold and discrimination tests. Presen-
tation of penswas always in sets of three (green – blue – red), separated
by about 20 s. Within triplets, colour-presentation was randomised. In
all tests, pens were presented directly underneath both nostrils for
about 2–3 s per pen. Pens were presented in intervals of approximately
3 s (allowing for a natural breath to be taken). Between the three olfac-
tion tasks a break of approx. 5 min was taken in an attempt to avoid
desensitisation. Scores fromeach test (threshold, discrimination, identi-
ﬁcation) were on scales of 1–16, all three tests were also combined into
a composite “TDI score” (score range: 1–48). The procedure lasted
approx. 30 min per participant.
The full methodological details are outlined in the supplementary
online information.
Secondly, participants completed the O-LIFE questionnaire, taking
approx. 25 min. The experiment (including the pre-questionnaires
and O-LIFE) lasted approx.1 h excluding breaks. Each cohort then per-
formed different neuropsychological tests which will not reported
here as they were carried out only in single cohorts (e.g. emotional
bias task, associative learning task). In cohorts that went on to investi-
gate additional cognitive tests (including a break if required) experi-
mental sessions lasted approx. 1.5-2 h.
The O-LIFE was presented on a computer and participants were re-
quired to press computer keys to indicate yes or no answers. Scores
for individual scales were calculated automatically.2.5. Statistics
Statistics were performed using SPSS [IBM Corp.Released 2015. IBM
SPSS Statistics for Windows, Version 23.0. Armonk,NY :IBM Corp.] ex-
cept for mediation analysis which used R version 3.3.1 [R Development
Core Team (2016) R: A Language and Environment for Statistical Com-
puting. R Foundation for Statistical Computing, Vienna]. Regression
analyses were carried out following conﬁrmation of normality, linearity
and homoscedasticity using Wilk-Shapiro, plots of residuals against
ﬁtted values and VIF scores respectively, graphs were plotted using
Graphpad Prism version 7.05 [Graphpad Software Inc. 2018].
The following abbreviations were used to describe the O-LIFE scales
in the reporting of results: Unusual experiences (UNEX), introvertive
anhedonia (INTAN), Cognitive disorganisation (COGDIS), impulsive
non-conformity (IMPNON).3. Results
3.1. Does composite olfaction score (TDI) predict total schizotypy score?
The composite olfactory score (TDI) was entered as predictor in lin-
ear regression analysis with total schizotypy score as the outcome vari-
able. The model was signiﬁcant (r2 = 0.01, β=−0.31, T=−2.7, p=
0.007), suggesting that overall olfactory score weakly predicts total
schizotypy score.3.2. Which olfactory measure best predicts total schizotypy score?
A hierarchical regression model with olfactory subscales entered in
the order identiﬁcation, discrimination and threshold, (order based on
prior literature) as predictors and schizotypy total as the outcome vari-
able was signiﬁcant (F3,728 = 3.996, P = 0.008). The model predicted
1.6% of the variancewith only threshold reaching individual signiﬁcance
(r2= 0.01, β=−0.61, T=−3.3, P b 0.001). This suggests that olfactory
threshold is the most predictive olfaction measure for total schizotypy.Please cite this article as: N. Mathur, C. Dawes and P.M.Moran, Olfactory th
phrenia Research, https://doi.org/10.1016/j.schres.2019.05.0143.3. Which schizotypy subscales are best predicted by which olfactory
measures?
A linear regression model with identiﬁcation, discrimination and
threshold olfactory subscales entered as predictors and UNEX as the
outcome variable was signiﬁcant (F3,728 = 4.6, P b 0.005). The overall
model predicted 1.9% of the variancewith only threshold reaching indi-
vidual signiﬁcance (β=−0.25, T=−3.5, P b 0.001).
A similar linear regression model with INTAN as the outcome vari-
able was signiﬁcant (F3,728= 2.6, P b 0.05). The overall model predicted
1.1% of the variance with only identiﬁcation reaching individual signiﬁ-
cance (β=−0.07, T=−2.1, P b 0.05).
Models with COGDIS and IMPNON as outcome variables were not
signiﬁcant. In summary olfactory threshold weakly predicts UNEX
while olfactory identiﬁcation weakly predicts INTAN.
3.4. Do sex, cannabis/cigarette smoking or reported presence of mental ill-
ness in the family affect schizotypy or olfaction?
Total schizotypy or UNEX were not signiﬁcantly different between
Males and Females (see Table 1). The subscale COGDISwas higher in fe-
males while IMPNON and INTAN were lower in females (see Table 1).
Smokers had higher scores on all schizotypy measures, these were sig-
niﬁcant for schizotypy total, UNEX and IMPNON (Table 1). Cannabis
smokers had higher scores only on IMPNON (Table 1). Individuals
reporting a history of mental illness in the family had higher scores on
all scales except IMPNON (Table 1).
In summary, report of smoking was associated with higher positive
schizotypy while report of a history of mental illness was associated
with higher scores on all schizotypy measures (except IMPNON). Fe-
males showed higher COGDIS while males showed higher INTAN and
IMPNON. As might be expected IMPNON was higher in cannabis
smokers and numerically higher in smokers (though this was not statis-
tically signiﬁcant for smokers).
None of these factors, sex, smoking, cannabis smoking or history of
mental illness showed any signiﬁcant independent effect on any of the
olfactory scales.
3.5. Does the prediction of positive schizotypy by olfactory threshold differ
between those who report and do not report a history of mental illness in
the family?
In the subset of participants (n = 126) that reported a history of
mental illness in the family a linear regression model with identiﬁca-
tion, discrimination and threshold olfactory subscales entered as predic-
tors and UNEX as outcome variable was signiﬁcant (F3,122 = 3.9, P b
0.01) (Fig. 1B). The overall model predicted 8.8% of the variance with
threshold reaching individual signiﬁcance (β=−0.23, T =−2.6, P b
0.01). In participants that report no history of mental illness in the fam-
ily (n = 320) the overall model was not signiﬁcant (F b 1) the model
predicted 0.5% of the variance (Fig. 1A). This was also reﬂected when
total schizotypy score was the outcome variable; the model predicted
9.2% of the variance in those reporting a history of mental illness and
0.6% in those reporting none.
To assess whether threshold and history of mental illness either in-
dependently predicted UNEX, or whether one variable may mediate
the other, three further linear regression models were conducted. In
the ﬁrst two models, UNEX was signiﬁcantly predicted by threshold
(F1,445 = 5.944, P b 0.01, r2 = 0.013) and history of mental health
(F1,446= 7.536, P b 0.01, r2= 0.016) in separate analyses.When adding
both variables as predictors simultaneously, each continued to be signif-
icant predictors of UNEX (F2,444 = 6.945, p = 0.001, adjusted R2 =
0.025), suggesting that both history of mental health and threshold in-
dependently predicted UNEX. Correlational analysis also supports this
conclusion. There was a signiﬁcant negative correlation between
UNEX and threshold in those reporting history of mental illness in thereshold selectively predicts positive psychometric schizotypy, Schizo-
Table 1
Mean (SD) O-LIFE scores by sex, smoking, cannabis and history of mental illness in family.
N UNEX Schizotypy total COGDIS INTAN IMPNON
Male 263 6.46(5.1) 28.99(13.5) 9.39(5.5) 5.01(3.9) 8.1(4.3)
Female 474 6.44(5.5) 28.63(13.9) 10.83(5.6) 4.37(4.0) 6.98(3.9)
F df value b1 b1 F1,735 = 10.9** F1,735 = 4.3* F1,735 = 16.5***
Non-smoker 564 6.49(5.2) 29.5(13.1) 10.6(5.4) 4.82(3.9) 7.5(3.9)
Smoker 106 7.93(6.2) 33.4(14.9) 11.58(6.2) 5.2(4.5) 8.6(4.2)
F df value F1,668 = 6.2** F1,668 = 7.5** b1 F1,668 = 7.0** b1
No cannabis 497 6.6(5.4) 29.7(13.5) 10.8(5.6) 4.9(4.0) 7.2(3.8)
Yes cannabis 92 7.3(6.4) 33.2(14.6) 11.3(5.7) 4.6((4.3) 9.9(4.3)
F df value b1 F2,589 = 2.5 NS b1 b1 F2,589 = 17.7****
No History 322 6.2(5.1) 27.6(12.2) 9.66(5.2) 4.3(3.6) 7.4(3.9)
Yes History 126 7.7(5.8) 34.6(15.3) 13(5.8) 5.9(5.3) 7.9(3.6)
F df value F1,446 = 7.5* F1,446 = 25.8**** F1,446 = 34.4**** F1,446 = 13.3**** b1
SD = standard deviation, df = degrees of freedom. *p b 0.05, **p b 0.01, ***p b 0.001p b 0.0001. UNEX = unusual experiences, COGDIS = cognitive, ****disorganisation, INTAN =
introvertive anhedonia, IMPNON= impulsive non-conformity. Note 1 respondent who checked ‘prefer not to say’ for history of mental illness question was excluded.
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Fig. 1. Plot of regression data for olfactory threshold and UNEX in subgroups of individuals asked whether they had a history of mental illness in their family (A & B) or whether they
smoked (C & D). Solid lines indicate best ﬁt regression line, dotted lines the 95% conﬁdence interval. Panel A indicates no signiﬁcant prediction of unusual experiences by olfactory
threshold in those reporting no, while panel B shows signiﬁcant prediction of UNEX by olfactory threshold in those reporting yes. Panels C and D show a trend that olfactory threshold
may predict UNEX better in smokers.
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Table 2
Pearson's correlation O-LIFE subscales by olfactory measures.
UNEX INTAN COG IMPNON
Not asked N = 285
Threshold −0.16 −0.08 −0.11 −0.16
Uncorrected p 0.005 NS NS 0.006
Identiﬁcation −0.06 −0.05 0.03 −0.11
Uncorrected p NS NS NS 0.04
Discrimination 0.00 −0.07 −0.00 −0.05
Uncorrected p NS NS NS NS
No history N = 322
Threshold −0.05 −0.03 −0.03 −0.02
Uncorrected p NS NS NS NS
Identiﬁcation 0.02 0.13 0.06 0.04
Uncorrected p NS 0.01 NS NS
Discrimination 0.01 −0.02 0.09 0.01
Uncorrected p NS NS NS NS
Yes history N = 126
Threshold −0.26⁎ −0.11 −0.06 −0.17
Uncorrected p 0.003 NS NS NS
Identiﬁcation −0.14 −0.08 −0.05 −0.02
Uncorrected p NS NS NS NS
Discrimination −0.13 −0.09 −0.28⁎ −0.17
Uncorrected p NS NS 0.001 NS
⁎ indicates p b 0.05 following Bonferroni correction for multiple comparisons. NS= p N
0.05. UNEX = unusual experiences, COGDIS = cognitive disorganisation, INTAN =
introvertive anhedonia, IMPNON= impulsive non-conformity.
Table 3
Spearman's ρ correlation UNEX and threshold by smoking and report of mental illness in
family.
Non-smoker Smoker
No history 0.01 −0.37⁎
N= 283 N= 38
Yes history −0.256⁎ −0.38
N= 100 N= 26
Not asked −0.13 −0.18
N= 178 N= 42
⁎ p b 0.05.
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seen in the group not asked the question (though this did not survive
multiple comparison correction; p b 0.06 after correction). No correla-
tion was seen in the group reporting no to history of mental illness in
the family (Table 2).
3.6. Does the prediction of negative schizotypy by olfactory identiﬁcation
differ between those who report and do not report a history of mental ill-
ness in the family?
A regressionmodelwith identiﬁcation, discrimination and threshold
olfactory subscales entered as predictors and INTAN as outcome vari-
able was not signiﬁcant in either those that reported a history ofmental
illness in the family or those that did not (both F's b 1). A positive corre-
lation between identiﬁcation and INTAN was found only in the group
that reported no history of mental illness in the family (Table 2), this
did not survive correction for multiple comparisons however.
3.7. Is cognitive disorganisation predicted by olfactory discrimination in
those who report history of mental illness in the family?
The overall regressionmodelwith all participants did not support pre-
diction of cognitive disorganisation by olfactory discrimination (see 3.3).
However Table 2 indicates a signiﬁcant correlation in the group reporting
history of mental illness. To explore this further we performed a regres-
sionmodel with threshold identiﬁcation and discrimination as predictors
and cognitive disorganisation as outcome variable in the group that re-
ported history of mental illness. The model was signiﬁcant (F3,122 = 3.6,
P b 0.01). The overall model predicted 8.2% of the variance with discrim-
ination reaching individual signiﬁcance (β=−0.27, T=−3.1, P b 0.01).
3.8. Does olfactory threshold predict positive schizotypy in individuals scor-
ing at or above the 75th percentile of schizotypy scores?
The previous analysis suggests that the association between positive
schizotypy and olfactory threshold was predominantly seen in those
reporting a history of mental illness.We also found that those reporting
a history ofmental illness have higher UNEX scores (Table 1).We inves-
tigated a subgroup of individuals at the 75th percentile score of 10 or
higher on UNEX with a view to investigating whether the associationPlease cite this article as: N. Mathur, C. Dawes and P.M.Moran, Olfactory th
phrenia Research, https://doi.org/10.1016/j.schres.2019.05.014between threshold and UNEX was mediated by higher UNEX scores. A
linear regression model with threshold olfactory subscale entered as
predictor and UNEX as outcome variable was signiﬁcant (F 1181 = 5.3,
P b 0.05) the model predicted 2.9% of the variance. To further explore
this relationship we investigated a hierarchical regression model with
threshold and history of mental illness (coded as a dummy variable)
and entered as predictors and UNEX as outcome variable. The model
with both threshold and history of mental illness was signiﬁcant
(F2,445 = 6.8, P b 0.001). Threshold alone predicted 1.1% of the UNEX
variance and was 3% when history of mental illness was added to the
model.With both threshold (β=−0.11, T=−2.5, P b 0.01) andhistory
of mental illness (β= 0.12, T=−2.7, P= 0.006) reaching individual
signiﬁcance. Threshold and UNEX were also found to be negatively cor-
related (r=−0.13, P b 0.0001) in this group but to a lesser degree than
the subgroup reporting a history ofmental illness (r=−0.26, P b 0.001)
(Table 2). This weaker correlation suggests that while the threshold/
UNEX or threshold/schizotypytotal associations are seen in the sub-
group reporting a history of mental illness, these associations may not
be mediated solely by the fact that they have high UNEX scores. Thus,
while reporting or not of a history of mental illness inﬂuences the asso-
ciation between threshold and UNEX, there is an independent albeit
weak residual association between olfactory threshold and UNEX in
those reporting no history.
3.9. How does smoking inﬂuence the association between reporting history
of mental illness in the family, threshold and positive schizotypy?
Table 3 indicates that the correlation between olfactory threshold and
UNEX differs depending on not only whether an individual reports a his-
tory of mental illness in the family (as we have deduced previously), but
also by smoking. In individuals not asked about smoking or history (sim-
ilar tomany studiesmeasuring psychometric schizotypy) correlations are
weak, however when stratiﬁed it can be seen that both smoking and his-
tory groups show signiﬁcant correlations Table 3). The non-smoking
group reporting no family history clearly does not show a correlation be-
tween threshold andUNEX. The numbers per group preclude a regression
analysis, however these data suggest that smoking and reporting ofmen-
tal illness in the family may have independent inﬂuence on the correla-
tion between threshold and UNEX (see also Fig. 1 A–D).
3.10. How does smoking inﬂuence the association between reporting his-
tory of mental illness in the family, identiﬁcation and negative schizotypy?
Table 4 indicates that unlike the threshold-UNEX association, the
correlation between olfactory identiﬁcation and INTAN does not differ
depending on whether an individual reports a history of mental illness
in the family in non-smokers. However when stratiﬁed it can be seen
that a correlation is found in smokers with no history of mental illness
but not in smokers who report a history. In common with the
threshold-UNEX correlation (Table 4) the non-smoking group reporting
no family history clearly does not show a correlation between identiﬁ-
cation and INTAN. The numbers per group preclude a regression analy-
sis, however these data suggest that smoking and reporting of mental
illness in the family may have independent inﬂuence on the associationreshold selectively predicts positive psychometric schizotypy, Schizo-
Table 4
Spearman's ρ correlation INTAN and identiﬁcation by smoking and report ofmental illness
in family.
Non-smoker Smoker
No history 0.07 −0.35⁎
N = 283 N = 38
Yes history −0.10 −0.02
N = 100 N = 26
Not asked 0.03 −0.20
N = 178 N = 42
⁎ p b 0.05.
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inﬂuence of these factors on the threshold-UNEX association. While
both correlations are highest in smokers the threshold-UNEX is higher
in those reporting history of mental illness while the Identiﬁcation-
INTAN correlation is highest in those who report no history of mental
illness.
4. Discussion
Olfactory threshold was found to weakly predict the positive symp-
tomdimensionUNEX, but not other schizotypymeasures. Thiswas seen
in those reporting yes to the question “is there a history ofmental illness
in your family”. This is theoretically consistent with ﬁndings of a deﬁcit
in olfactory threshold in several studies in patients with schizophrenia
(Chen et al., 2018; Isseroff et al., 1987; Kamath et al., 2018; Rupp et al.,
2005a; Rupp et al., 2005b; Turetsky andMoberg, 2009). A speciﬁc asso-
ciation with positive symptom-related dimension is also consistent
with patient studies where Chen et al., (2017) found an association be-
tween olfactory threshold and positive symptoms while Kamath et al.
(2018) showed that threshold for one odorant citralva was associated
with clinician rated positive symptomatology. Other studies (Auster
et al., 2014) have found no associations with positive symptomatology
though these used composite measures of olfactory accuracy, not
being sufﬁciently powered to analyse measures of speciﬁc subscales.
One factor suggested to affect threshold sensitivity is dryness of the
nasal mucosa induced by antipsychotic drugs, which may mediate
threshold deﬁcits in patient studies (Isseroff et al., 1987). Meta-
analysis has additionally identiﬁed duration of illness as a moderator
of general olfactory deﬁcits (Moberg et al., 2014), also raising the possi-
bility that length of time on medication might affect olfaction. An asso-
ciation between olfactory threshold and positive symptomatology
suggests that at least conceptually, this association can be demonstrated
in individuals not currently taking antipsychotic medication.
Meta-analyses of patient studies have indicated that odour memory
or olfactory identiﬁcation showed the largest effect sizes and threshold
the smallest (Cohen et al., 2012; Kamath et al., 2014; Moberg et al.,
2014). It is therefore surprising that threshold was the aspect identiﬁed
here. It should be noted that different studies have used different
odourants for the threshold testing, we used N-butanol here which is
one of the most common but several studies have used citralva or
lyrol, though there has been little difference found between them in
terms of demonstrating a clinical deﬁcit in patient groups (Kamath
et al., 2018; Turetsky and Moberg, 2009).
We found a weaker trend for a negative association between identi-
ﬁcation and the negative symptom scale INTAN. Identiﬁcation deﬁcits in
schizophrenia patients are themost widely reported and have the larg-
est effect sizes (Kamath and Bedwell, 2008). The correlation in this
study was positive but did not survive multiple correction therefore is
a trend only. This direction of effect, if not effect size, is nonetheless con-
sistent with a number of studies in patients e.g. (Chen et al., 2018;
Kamath et al., 2018). Kamath et al., (2017) reported identiﬁcation deﬁ-
cits were associated with self-reported anhedonia and clinician rated
negative symptoms. It should be noted that these prior studies addition-
ally found discrimination deﬁcits. We also found discriminationPlease cite this article as: N. Mathur, C. Dawes and P.M.Moran, Olfactory th
phrenia Research, https://doi.org/10.1016/j.schres.2019.05.014predicted cognitive disorganisation, this was not seen in our full sample
analysis butwas evident in the group reporting history ofmental illness.
This is congruent with Kamath's prior ﬁndings of discrimination deﬁcits
in patients and their relatives and may suggest some selectivity of this
olfactory measure for cognitive symptoms.
We found that the association between olfactory threshold and UNEX
is seen in those reporting a history of mental illness in the family with a
weaker trend in the group of individuals not asked the question. While
there have been many clinical studies that have investigated relatives of
people with schizophrenia, this factor is sometimes not considered in
non-clinical population studies. Family history is a signiﬁcant risk factor
for most psychiatric disorders and its measurement is becoming increas-
ingly common in large scale genetic studies and in clinical practice (Milne
et al., 2009). There aremany studies that have shown that risk for psycho-
sis is higher in those reporting a family history of psychosis in both pa-
tients and non-patients (Esterberg et al., 2010; Seidman et al., 2012).
We conﬁrmed that those reporting yes to mental illness in the family
have signiﬁcantly higher schizotypy scores on all scales with the excep-
tion of IMPNON. As IMPNON is included as a control scale not directly re-
lated to schizophrenia symptom dimensions (Mason et al., 1995), this is
consistent with theory. We have not speciﬁed mental illness therefore
wemight expect to have included relatives of peoplewith other disorders
such as depression, anxiety or bipolar. The closeness of the relationship
was not interrogated by this general question either, therefore we
might expect both ﬁrst and second degree relatives to have responded
yes. This could readily be included in future studies as there are a number
of clinical instruments that can address this question comprehensively
e.g. (Milne et al., 2009). Whether an individual might declare a history
of mental illness in the family might be inﬂuenced by a number of differ-
ent factors and may reﬂect other factors such as personality or demand
characteristics. The onlymeasure thatmight approximate this in the pres-
ent study is IMPNON, forwhichwedid not see a difference between those
reporting, not reporting or not asked about history of mental illness, sug-
gesting impulsive behaviour increasing probability to respond yes is un-
likely to have mediated the effect.
Despite clinical studies suggesting that smoking does not affect olfac-
tory deﬁcits (Corcoran et al., 2005; Moberg et al., 2014), it is possible that
those reporting a history of mental illness may be more likely to smoke
and this could be a mediating variable. Here in agreement with other
studies we found that smokers have higher schizotypy scores (Stewart
et al., 2010) and this appears to be associated with the positive symptom
dimension. We also found that the UNEX/olfactory threshold correlation
is not seen in non-smokers who do not report a family history of mental
illness but is in non-smokers that do, aswell as in smokerswho do not re-
port a history of mental illness. This suggests that either smoking or his-
tory of mental illness in the family can independently inﬂuence the
expression of the association between UNEX and olfactory threshold. Re-
gression models suggest that taken independently, smoking and
reporting of family history of mental illness are sufﬁcient but not neces-
sary for the demonstration of the association between positive schizotypy
and olfactory threshold identiﬁed in this study.
When we investigated the weak identiﬁcation-INTAN correlation in
detail, we found that correlation was seen only in smokers with no his-
tory. This suggests that smokingor history ofmental illness in the family
can independently inﬂuence the association between identiﬁcation and
INTAN. For history of mental illness this differs qualitatively from how
these factors inﬂuence the threshold-UNEX correlation. Why this
would be absent in those with history of mental illness is not clear, it
is unlikely to be attributable to different INTAN proﬁles between the
groups as the groups have similar mean values and range [mean
INTAN non-smoking no history group 4.2 range 0–21; mean INTAN
non-smoking yes history group 4.4 range 0–19]. These scores are low
compared to published norms for INTAN scores for a similar age group
which average approx. 5–6 depending on sex (Mason and Claridge,
2006). Extreme low scores may indicate some other pathology or
some adaptation in response to pathology. Low schizotypy scale scoresreshold selectively predicts positive psychometric schizotypy, Schizo-
7N. Mathur et al. / Schizophrenia Research xxx (xxxx) xxxare not necessarily indicators of extreme psychological health and may
instead describe absence of schizotypal deviance (Lenzenweger, 2015).
Given the predictive effects of smoking and olfactionwe additionally
asked the question whether they could predict reporting of history of
mental illness. Using logistic regression we found that while smoking
showed a predictive effect, threshold did not (this is discussed further
in supplementary information).
A limitation of this study is that single-questionmeasures of smoking
and history of mental health in the family are simplistic and do not allow
differentiation from ex-smokers, degree of smoking, relationship to fam-
ily member, type of mental illness or demand characteristics which may
limit interpretations of the data in terms of understanding mechanisms.
However the simplicity of the measures also means that either or both
could be readily implemented in future studies.
In summary we have established that lower olfactory threshold is
weakly but signiﬁcantly associated with higher unusual experiences in
non-clinical participants, but that the expression of this association
can be moderated by smoking and reported history of mental illness
in the family. This may help to explain variable inconsistent ﬁndings
in prior studies. We found weak evidence for an association between
olfactory identiﬁcation and negative symptom relevant scale and no
evidence for an association between olfactory discrimination and
schizotypal characteristics, with the exception of aweak negative corre-
lation with cognitive disorganisation in those reporting history of
mental illness. These data support prior suggestions that olfactory ab-
normality may prove useful as a biomarker for premorbid psychosis
and suggest the threshold measure may have some selectivity for
characteristics related to positive symptoms. It is suggested that future
studies of olfaction and psychometrically deﬁned schizotypy (and po-
tentially any psychometric schizotypy study) consider stratiﬁcation by
smoking and history of mental illness in the family.
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